Description

Lomustine Medak Capsules 40 mg. №20

Ingredients:

Each capsule contains 40 mg of Lomustine.

Dosage:

The usual dose is 130-160 mg/m² as a single dose every 6 weeks.

Indications:

Lomustine Medak is indicated for the treatment of certain types of brain tumors, Hodgkin’s disease, and malignant melanoma.

Contraindications:

Do not use Lomustine if you have bone marrow suppression or severe hepatic or renal impairment.

Directions:

Take Lomustine capsules orally with plenty of water. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence:

Lomustine, a nitrosourea compound, exerts its antitumor effects by alkylating DNA strands, leading to DNA breaks and ultimately cell death. Studies have shown its efficacy in treating various types of cancers, especially brain tumors and lymphomas.

Additional Information:

Lomustine Medak capsules should be handled with care and only used under the supervision of a qualified healthcare professional due to its potent cytotoxic effects. Regular monitoring of blood counts and liver function is essential during treatment to manage potential side effects.

Research has demonstrated the effectiveness of Lomustine in combination therapies and as an adjuvant treatment post-surgery in certain cancer types. Clinical trials have shown promising results in improving overall survival rates and quality of life in patients with advanced malignancies.